| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.0056 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |